4//SEC Filing
Febbo Phillip G. 4
Accession 0001384101-25-000032
CIK 0001384101other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 4:42 PM ET
Size
6.9 KB
Accession
0001384101-25-000032
Insider Transaction Report
Form 4
VERACYTE, INC.VCYT
Febbo Phillip G.
Chief Scientific & Med Officer
Transactions
- Sale
Common Stock
2025-03-04$32.86/sh−4,467$146,808→ 86,110 total - Sale
Common Stock
2025-03-04$33.95/sh−3,570$121,205→ 82,540 total
Footnotes (3)
- [F1]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 4, 2024.
- [F2]Represents weighted average sales price. Sale prices for the transactions range from $32.50 to $33.33. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
- [F3]Represents weighted average sales price. Sale prices for the transactions range from $33.56 to $34.42. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Documents
Issuer
VERACYTE, INC.
CIK 0001384101
Entity typeother
Related Parties
1- filerCIK 0001649245
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 4:42 PM ET
- Size
- 6.9 KB